Pee Cee Cosma Sope Limited (524136) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Pee Cee Cosma Sope Limited ₹505, price ₹474, upside +6.5%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Pee Cee Cosma Sope Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹87.87 – ₹893.66 · fair‑value band ₹356.96 – ₹656.73 · the ₹474.20 price screens below the ₹505.18 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Pee Cee Cosma Sope in your weekly email
Every Wednesday you see whether Pee Cee Cosma Sope is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Pee Cee Cosma Sope Limited manufactures and sells soaps and detergents, cleaning and polishing preparations, perfumes, and toilet preparations in India. Its products primarily include detergent powders and cakes, and laundry soaps. The company offers its products through a network of distributors and retailers under the Doctor brand name.
Show more
Pee Cee Cosma Sope Limited manufactures and sells soaps and detergents, cleaning and polishing preparations, perfumes, and toilet preparations in India. Its products primarily include detergent powders and cakes, and laundry soaps. The company offers its products through a network of distributors and retailers under the Doctor brand name. Pee Cee Cosma Sope Limited was founded in 1947 and is based in Agra, India.
Stock analysis
Pee Cee Cosma Sope Limited (524136) currently trades at ₹474.20, while our model-based Fair Value estimate is ₹505.18, so the stock looks roughly fairly valued today (gap 6.1%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹786.72 per share, and 19 of the 26 models we run sit above the ₹474.20 price.
Bear case: the Asset-Based group reads lowest at ₹142.08, and 7 of the 26 models stay below the price. Evidence for this calculation is medium.
Scenario range: ₹356.96 (bear) to ₹656.73 (bull), the price of ₹474.20 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Consumer Goods sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Pee Cee Cosma Sope Limited reported revenue of ₹1.6B in FY2026 versus ₹927M in FY2022, a compound +14.3%/yr. Reported net income was ₹83.3M in FY2026, compounding +49.1%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.
Key figures
Market cap ₹246M (≈ $2.6M) · P/E ratio 6.8 · P/S ratio 0.36 · EPS (TTM) ₹13.66 · Dividend yield 6.4% · Net margin 5.3% · Return on equity 14.7% · Return on assets (EBIT) 15.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 7% below its 52-week high and 62% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Goods peers we cover trades at −30% fair-value upside, at 7%, 524136 screens cheaper than that median.
Fair Value models
Bear ₹356.96Fair Value ₹505.18Bull ₹656.73
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹3.90 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+12.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.9%
Start year 2021 (pandemic). Over 10 years: +7.8% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+38.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+31.7%
Dividend (yield on the price)6.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.31.7% vs 18.4%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 7%
Start year 2021 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about −3.3% a year for the price.
Compare Pee Cee Cosma Sope Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Personal Products” was too small, so the broader sector is used.)Consumer Staples · 1683 stocks
Beats the sector median on 9/9 measures
Overall it ranks above its sector peers.
Valuation
Quality Score67 · Top 25%
Fair Value upside+30.7% · Above median
Profitability
Return on equity (TTM)14.7% · Top 25%
Return on assets9.1% · Top 25%
Net margin (TTM)4.6% · Above median
Operating margin (TTM)6.3% · Above median
Growth and dividend
Revenue growth19.4% · Top 25%
Dividend yield (TTM)6.4% · Top 25%
Valuation Multiplesvs Consumer Staples median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Pee Cee Cosma Sope Limited (524136) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹505.18 versus a price of ₹474.20, about +7% upside (fairly valued).
What is the fair value of 524136?
Our model-based fair value for Pee Cee Cosma Sope Limited is ₹505.18 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹474.20.
What is the quality score of 524136?
Pee Cee Cosma Sope Limited has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Pee Cee Cosma Sope Limited (524136)?
Our model-based price target is the fair value of ₹505.18 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario ₹356.96, optimistic scenario ₹656.73. It is a calculation from audited fundamentals, not an analyst target.
What is the Pee Cee Cosma Sope Limited stock forecast for 2026?
Our models put fair value at ₹505.18, about +7% upside versus a price of ₹474.20 (fairly valued). Cautious scenario ₹356.96, optimistic scenario ₹656.73. The calculation is refreshed regularly with new filings.
What is the revenue of Pee Cee Cosma Sope Limited (524136)?
Pee Cee Cosma Sope Limited reported trailing-twelve-month revenue of about ₹781M (latest available figure, as of Sep 24, 2026).
Does Pee Cee Cosma Sope Limited pay a dividend?
Pee Cee Cosma Sope Limited currently shows a dividend yield of about 6.41% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Pee Cee Cosma Sope Limited (524136)?
For today's price to be fair in a discounted-cash-flow model, Pee Cee Cosma Sope Limited would have to grow free cash flow by +0.7 % per year for five years (discount rate 13.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.9 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 524136 use?
Our models discount Pee Cee Cosma Sope Limited at 13.5 %: a base by market capitalisation (nano), damped by beta 1.36, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Pee Cee Cosma Sope Limited that is +0.7 % per year a year over ten years, using the same discount rate (13.5 %) and the same formula as our fair value.
How much growth has Pee Cee Cosma Sope Limited (524136) delivered so far?
Over the past 5 years revenue at Pee Cee Cosma Sope Limited grew +13.9 % a year. The price currently implies +0.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
What is the free cash flow yield of Pee Cee Cosma Sope Limited (524136)?
The free-cash-flow yield on the price is 11.14 %: that much free cash flow Pee Cee Cosma Sope Limited produces per unit of market value. When it exceeds the discount rate of our models (13.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Pee Cee Cosma Sope Limited (524136)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Pee Cee Cosma Sope Limited it is ₹505.18 per share (as of Sep 24, 2026), against a price of ₹474.20. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Pee Cee Cosma Sope Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 524136 trades below its calculated fair value: price ₹474.20, fair value ₹505.18, a gap of about +7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 524136?
No. The price is what the market pays today (₹474.20); the fair value is what the company's own numbers justify (₹505.18). For Pee Cee Cosma Sope Limited the two are ₹30.98 per share apart. That gap is exactly why we show both numbers side by side.
How much is Pee Cee Cosma Sope Limited worth?
The market values Pee Cee Cosma Sope Limited at about ₹246M (market capitalisation, as of Sep 24, 2026). Per share that is ₹474.20; our models calculate a fair value of ₹505.18 per share.
What do the bullish and bearish scenarios say about 524136?
Our models span a range for Pee Cee Cosma Sope Limited: cautious scenario ₹356.96, base ₹505.18, optimistic ₹656.73 per share (as of Sep 24, 2026, price ₹474.20). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 524136?
Pee Cee Cosma Sope Limited trades at a price-to-earnings ratio of 6.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹505.18 is built from several models across several years.
How solid is the balance sheet of Pee Cee Cosma Sope Limited (524136)?
Balance-sheet figures for Pee Cee Cosma Sope Limited (as of Sep 24, 2026): return on equity 14.7%. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is 524136 from its 52-week high?
Pee Cee Cosma Sope Limited trades at ₹474.20, about 7% below its 52-week high of ₹512.30 and 62% above the low of ₹292.55 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹505.18 is for.
Which stocks are comparable to Pee Cee Cosma Sope Limited?
From the same area (Consumer Goods) we also value Ador Multiproducts Limited, HALDYNGL, TRITONV, Saint-Gobain Sekurit India Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Pee Cee Cosma Sope Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹474.20, calculated fair value ₹505.18 (+7%), Quality Score 67/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 524136 calculated?
We run Pee Cee Cosma Sope Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹505.18, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Pee Cee Cosma Sope Limited currently trades 6 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Pee Cee Cosma Sope Limited (524136)?
The closing price on Oct 1, 2026 was ₹474.20. Our model-based fair value is ₹505.18, about +7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Pee Cee Cosma Sope Limited right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (₹356.96 to ₹656.73) leaves room in how you read the outcome.
Key figures of Pee Cee Cosma Sope Limited
How large is the market capitalisation of Pee Cee Cosma Sope Limited (524136)?
The market capitalisation of Pee Cee Cosma Sope Limited is ₹246M (≈ $2.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Pee Cee Cosma Sope Limited (524136)?
The price-to-sales ratio of Pee Cee Cosma Sope Limited is 0.36 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Pee Cee Cosma Sope Limited (524136)?
Earnings per share at Pee Cee Cosma Sope Limited are ₹13.66 (price ÷ EPS = P/E 6.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Pee Cee Cosma Sope Limited (524136)?
The dividend yield of Pee Cee Cosma Sope Limited is 6.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Pee Cee Cosma Sope Limited (524136)?
The net margin of Pee Cee Cosma Sope Limited is 5.3% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Pee Cee Cosma Sope Limited (524136)?
The return on equity (ROE) of Pee Cee Cosma Sope Limited is 14.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Pee Cee Cosma Sope Limited (524136)?
On an EBIT basis the return on assets of Pee Cee Cosma Sope Limited is 15.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Pee Cee Cosma Sope Limited (524136)?
The operating margin of Pee Cee Cosma Sope Limited is 6.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Pee Cee Cosma Sope Limited (524136)?
Revenue at Pee Cee Cosma Sope Limited is growing +19.4% versus a year earlier (3y avg +8.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Pee Cee Cosma Sope Limited (524136)?
Earnings per share at Pee Cee Cosma Sope Limited are growing +350% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Pee Cee Cosma Sope Limited (524136) carry?
The net debt of Pee Cee Cosma Sope Limited is ₹5.6M (fiscal year 2025, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Pee Cee Cosma Sope Limited in the live analysis
One click puts Pee Cee Cosma Sope Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
